5-894996-CA-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The ENST00000166345.8(TRIP13):c.258+48delA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.154 in 1,556,302 control chromosomes in the GnomAD database, including 37,006 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.31 ( 13758 hom., cov: 26)
Exomes 𝑓: 0.14 ( 23248 hom. )
Consequence
TRIP13
ENST00000166345.8 intron
ENST00000166345.8 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00
Genes affected
TRIP13 (HGNC:12307): (thyroid hormone receptor interactor 13) This gene encodes a protein that interacts with thyroid hormone receptors, also known as hormone-dependent transcription factors. The gene product interacts specifically with the ligand binding domain. This gene is one of several that may play a role in early-stage non-small cell lung cancer. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 5-894996-CA-C is Benign according to our data. Variant chr5-894996-CA-C is described in ClinVar as [Benign]. Clinvar id is 1225568.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.752 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIP13 | NM_004237.4 | c.258+48delA | intron_variant | ENST00000166345.8 | NP_004228.1 | |||
TRIP13 | NM_001166260.2 | c.258+48delA | intron_variant | NP_001159732.1 | ||||
TRIP13 | XM_011514163.2 | c.258+48delA | intron_variant | XP_011512465.1 | ||||
TRIP13 | XM_047417879.1 | c.-202+48delA | intron_variant | XP_047273835.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIP13 | ENST00000166345.8 | c.258+48delA | intron_variant | 1 | NM_004237.4 | ENSP00000166345.3 | ||||
TRIP13 | ENST00000512024.5 | n.373+48delA | intron_variant | 1 | ||||||
TRIP13 | ENST00000513435.1 | c.243+48delA | intron_variant | 5 | ENSP00000427528.1 | |||||
TRIP13 | ENST00000508456.1 | n.232+48delA | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.314 AC: 47638AN: 151920Hom.: 13697 Cov.: 26
GnomAD3 genomes
AF:
AC:
47638
AN:
151920
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.200 AC: 41955AN: 210044Hom.: 7733 AF XY: 0.184 AC XY: 21019AN XY: 114036
GnomAD3 exomes
AF:
AC:
41955
AN:
210044
Hom.:
AF XY:
AC XY:
21019
AN XY:
114036
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.137 AC: 192097AN: 1404264Hom.: 23248 Cov.: 22 AF XY: 0.137 AC XY: 95051AN XY: 695528
GnomAD4 exome
AF:
AC:
192097
AN:
1404264
Hom.:
Cov.:
22
AF XY:
AC XY:
95051
AN XY:
695528
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.314 AC: 47766AN: 152038Hom.: 13758 Cov.: 26 AF XY: 0.312 AC XY: 23195AN XY: 74332
GnomAD4 genome
AF:
AC:
47766
AN:
152038
Hom.:
Cov.:
26
AF XY:
AC XY:
23195
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1131
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 26, 2019 | - - |
Oocyte maturation defect 9 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Mosaic variegated aneuploidy syndrome 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at